Literature DB >> 33673244

A Toxic Synergy between Aluminium and Amyloid Beta in Yeast.

Jamieson B Mcdonald1, Sudip Dhakal1, Ian Macreadie1.   

Abstract

Alzheimer's disease (AD), the most prevalent, age-related, neurodegenerative disease, is associated with the accumulation of amyloid beta (Aβ) and oxidative stress. However, the sporadic nature of late-onset AD has suggested that other factors, such as aluminium may be involved. Aluminium (Al3+) is the most ubiquitous neurotoxic metal on earth, extensively bioavailable to humans. Despite this, the link between Al3+ and AD has been debated for decades and remains controversial. Using Saccharomyces cerevisiae as a model organism expressing Aβ42, this study aimed to examine the mechanisms of Al3+ toxicity and its interactions with Aβ42. S. cerevisiae cells producing Aβ42 treated with varying concentrations of Al3+ were examined for cell viability, growth inhibition, and production of reactive oxygen species (ROS). Al3+ caused a significant reduction in cell viability: cell death in yeast producing green fluorescent protein tagged with Aβ42 (GFP-Aβ42) was significantly higher than in cells producing green fluorescent protein (GFP) alone. Additionally, Al3+ greatly inhibited the fermentative growth of yeast producing GFP-Aβ42, which was enhanced by ferric iron (Fe3+), while there was negligible growth inhibition of GFP cells. Al3+- induced ROS levels in yeast expressing native Aβ42 were significantly higher than in empty vector controls. These findings demonstrate Al3+ has a direct, detrimental toxic synergy with Aβ42 that can be influenced by Fe3+, causing increased oxidative stress. Thus, Al3+ should be considered as an important factor, alongside the known characteristic hallmarks of AD, in the development and aetiology of the disease.

Entities:  

Keywords:  Alzheimer’s disease; Fenton chemistry; aluminium; amyloid beta; iron; oxidative stress; yeast

Mesh:

Substances:

Year:  2021        PMID: 33673244      PMCID: PMC7918211          DOI: 10.3390/ijms22041835

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  51 in total

1.  Aluminum-triggered structural modifications and aggregation of beta-amyloids.

Authors:  F Ricchelli; D Drago; B Filippi; G Tognon; P Zatta
Journal:  Cell Mol Life Sci       Date:  2005-08       Impact factor: 9.261

2.  Reversal of an aluminium induced alteration in redox status in different regions of rat brain by administration of centrophenoxine.

Authors:  Bimla Nehru; Punita Bhalla
Journal:  Mol Cell Biochem       Date:  2006-09-13       Impact factor: 3.396

3.  Aluminum in hippocampal neurons from humans with Alzheimer's disease.

Authors:  J R Walton
Journal:  Neurotoxicology       Date:  2006-02-03       Impact factor: 4.294

Review 4.  Biometals and their therapeutic implications in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 5.  Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

6.  Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study.

Authors:  K S Rao; G V Rao
Journal:  Mol Cell Biochem       Date:  1994-08-17       Impact factor: 3.396

Review 7.  Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies.

Authors:  Piyoosh Sharma; Pavan Srivastava; Ankit Seth; Prabhash Nath Tripathi; Anupam G Banerjee; Sushant K Shrivastava
Journal:  Prog Neurobiol       Date:  2018-12-30       Impact factor: 11.685

Review 8.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

9.  Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-β (Aβ) Toxicity in Yeast.

Authors:  Xin Chen; Markus M M Bisschops; Nisha R Agarwal; Boyang Ji; Kumaravel P Shanmugavel; Dina Petranovic
Journal:  Front Mol Neurosci       Date:  2017-07-27       Impact factor: 5.639

Review 10.  Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.

Authors:  Yong Li; Qian Jiao; Huamin Xu; Xixun Du; Limin Shi; Fengju Jia; Hong Jiang
Journal:  Front Mol Neurosci       Date:  2017-10-24       Impact factor: 5.639

View more
  1 in total

1.  Schisandrin alleviates the cognitive impairment in rats with Alzheimer's disease by altering the gut microbiota composition to modulate the levels of endogenous metabolites in the plasma, brain, and feces.

Authors:  Chengqin Zhang; Ying Zhang; Tiantian Zhao; Tingting Mou; Wang Jing; Jian Chen; Wenqian Hao; Shuo Gu; Meirong Cui; Yue Sun; Binbin Wei
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.